<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T15:53:01Z</responseDate>
  <request identifier="oai:figshare.com:article/34034680" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034680</identifier>
        <datestamp>2026-09-30T17:26:53Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Effects of AZP2006 on TH(+) primary mesencephalic neurons injured by MPP&lt;sup&gt;+&lt;/sup&gt; (4 µM) for 48 h (A-D) or with Rotenone (10 nM) for 24 h (E-H).&lt;/p&gt;</dc:title>
          <dc:creator>Noelle Callizot (5660677)</dc:creator>
          <dc:creator>Georgia Culley (15148575)</dc:creator>
          <dc:creator>Grace Flower (25145065)</dc:creator>
          <dc:creator>Laura Rouvière (16400955)</dc:creator>
          <dc:creator>Véronique De Conto (25145068)</dc:creator>
          <dc:creator>Alexandre Wojcinski (6340172)</dc:creator>
          <dc:creator>Catherine Botto (25145071)</dc:creator>
          <dc:creator>Cecilia Estrella (1618609)</dc:creator>
          <dc:creator>Alexandre Henriques (359791)</dc:creator>
          <dc:creator>Philippe Verwaerde (1618624)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>promising therapeutic approach</dc:subject>
          <dc:subject>lewy bodies ).</dc:subject>
          <dc:subject>several lysosomal enzymes</dc:subject>
          <dc:subject>restoring lysosomal homeostasis</dc:subject>
          <dc:subject>lysosomal availability depend</dc:subject>
          <dc:subject>like models (&lt;</dc:subject>
          <dc:subject>parkinson &amp;# 8217</dc:subject>
          <dc:subject>maintaining lysosomal function</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>neuroprotective effects involve</dc:subject>
          <dc:subject>several parkinson ’</dc:subject>
          <dc:subject>lysosomal function</dc:subject>
          <dc:subject>neuroprotective effects</dc:subject>
          <dc:subject>lysosomal system</dc:subject>
          <dc:subject>lysosomal dysfunction</dc:subject>
          <dc:subject>parkinson ’</dc:subject>
          <dc:subject>neuroprotective action</dc:subject>
          <dc:subject>disease models</dc:subject>
          <dc:subject>vivo &lt;/</dc:subject>
          <dc:subject>vitro &lt;/</dc:subject>
          <dc:subject>ultimately supporting</dc:subject>
          <dc:subject>prone proteins</dc:subject>
          <dc:subject>pathohistological hallmarks</dc:subject>
          <dc:subject>mitochondrial injury</dc:subject>
          <dc:subject>genetic connections</dc:subject>
          <dc:subject>endoplasmic reticulum</dc:subject>
          <dc:subject>dopaminergic neurons</dc:subject>
          <dc:subject>direct link</dc:subject>
          <dc:subject>clinical development</dc:subject>
          <dc:description>&lt;p&gt;ICC analysis of cultures shows the total number of TH(+) neurons (A,E), the length of their neurite network (B,F), the area of cytoplasmic α-syn per TH(+) neuron (C,G) and lysosome burden as area of LAMP2(+) vesicles per TH(+) neuron (D and H), expressed as % of control (CTR). Raw values for MPP&lt;sup&gt;+&lt;/sup&gt; &amp; Rotenone CTR (i.e., 100%); sum TH(+) neurons per well, i.e., per biological replicate = 18 ± 0.5 &amp; 26 ± 1; neurite network = 889 ± 57 &amp; 929 ± 24 µm; α-syn area/TH(+) neuron = 29 ± 2.1 &amp; 28 ± 1 µm&lt;sup&gt;2&lt;/sup&gt;; ratio LAMP2/TH(+) = 10 ± 0.3 &amp; 10 ± 0.5, respectively. Each bar represents the mean ± SEM, one-way ANOVA followed by Fisher’s test. &lt;sup&gt;####&lt;/sup&gt;p &lt; 0.0001 from CTR and *p &lt; 0.05, **p &lt; 0.01; ***p &lt; 0.001 or ****p &lt; 0.0001 from MPP&lt;sup&gt;+&lt;/sup&gt; or Rotenone treatment, (n = 4-6 / group).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:26:42Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0359269.g002</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Effects_of_AZP2006_on_TH_primary_mesencephalic_neurons_injured_by_MPP_sup_sup_4_M_for_48_h_A-D_or_with_Rotenone_10_nM_for_24_h_E-H_p_/34034680</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
